Catalyst Wire Dossier Catalyst Wire Dossier

BUCAPSOL

buspirone hydrochloride · PANGEA PHARMACEUTICALS, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BUCAPSOL, covering 2025-03-13 to 2025-10-17. Get the full timeline:

Most recent: FDA Approved: BUCAPSOL — Supplemental Application (PANGEA PHARMACEUTICALS, LLC)

See pricing